{
  "ticker": "ASML",
  "year": 2016,
  "name": "ASML",
  "ir_url": "",
  "data": {
    "Income Statement": {
      "Total net sales": "6,795.4",
      "Net system sales": "5,258.5",
      "Net service and field option sales": "1,536.9",
      "Total cost of sales": "3,055.7",
      "Cost of system sales": "2,116.1",
      "Cost of service and field option sales": "939.6",
      "Gross profit": "3,739.7",
      "Research and development (R&D) costs": "1,105.4",
      "Selling, general and administrative (SG&A) costs": "320.2",
      "Income from operations": "2,314.1",
      "Interest and other, net": "2.2",
      "Income before income taxes": "2,316.3",
      "Income tax expense": "351.4",
      "Income after income taxes": "1,964.9",
      "Profit from equity method investments": "38.1",
      "Net income": "2,003.0",
      "Cost of sales": "3,055.7",
      "Selling, general and administrative costs": "320.2",
      "Revenue from contracts with customers": "6,795.4",
      "Wages and salaries": "1,005.4",
      "Social security expenses": "95.6",
      "Pension and retirement expenses": "71.3",
      "Share-based payments": "37.3",
      "Personnel expenses": "1,209.6",
      "Board of Management": "4.1",
      "Former Board of Management": "0.7",
      "Other employees": "697.0",
      "Total STI bonus expenses": "701.8",
      "Pension plan based on multi-employer union plan": "13.1",
      "Pension plans based on defined contribution and other plans": "58.2",
      "Income tax (expense) / benefit current": "417.2",
      "Income tax (expense) / benefit deferred": "-65.8",
      "Income tax (expense) / benefit Netherlands": "307.0",
      "Income tax (expense) / benefit Foreign": "44.4",
      "Total income tax (expense) / benefit current": "417.2",
      "Total income tax (expense) / benefit deferred": "-65.8",
      "Total income tax (expense) / benefit": "351.4",
      "Income tax expense based on ASML’s domestic rate": "579.1",
      "Effects of tax rates in foreign jurisdictions": "-5.9",
      "Adjustments in respect of tax incentives": "-237.1",
      "Adjustments in respect of prior years’ current taxes": "-16.0",
      "Adjustments in respect of prior years’ deferred taxes": "8.3",
      "Movements in the liability for unrecognized tax benefits": "-0.7",
      "Global minimum tax (expense) / benefit": "N/A",
      "Change in valuation allowance": "-4.8",
      "Equity method investments": "-3.2",
      "Other (credits) and non-tax deductible items": "-3.3",
      "Basic net income per ordinary share": "4.66",
      "Diluted net income per ordinary share": "4.61"
    },
    "Balance Sheet": {
      "Total shareholder equity": "8,064.7",
      "Balance sheet total": "18,411.1",
      "Cash and cash equivalents": "3,476.4",
      "Short-term investments": "0.0",
      "Accounts receivable, net": "1,255.5",
      "Finance receivables, net": "216.9",
      "Current tax assets": "112.5",
      "Contract assets": "N/A",
      "Inventories, net": "2,248.4",
      "Other assets": "239.1",
      "Total current assets": "7,548.8",
      "Deferred tax assets": "403.5",
      "Loans receivable": "327.0",
      "Equity method investments": "597.6",
      "Goodwill": "1,932.9",
      "Other intangible assets, net": "317.6",
      "Property, plant and equipment, net": "2,343.4",
      "Right-of-use assets": "N/A",
      "Total non-current assets": "5,921.0",
      "Total assets": "18,411.1",
      "Accounts payable": "1,041.3",
      "Accrued and other liabilities": "1,254.2",
      "Current tax liabilities": "148.1",
      "Current portion of long-term debt": "6.3",
      "Contract liabilities": "N/A",
      "Total current liabilities": "3,010.7",
      "Long-term debt": "1,493.3",
      "Deferred and other income tax liabilities": "237.6",
      "Total non-current liabilities": "1,973.1",
      "Total liabilities": "4,983.8",
      "Issued and outstanding shares": "431.2",
      "Share premium": "1,659.2",
      "Treasury shares at cost": "-1,586.4",
      "Retained earnings": "7,018.6",
      "Accumulated other comprehensive income": "-26.7",
      "Total shareholders’ equity": "8,064.7",
      "Total liabilities and shareholders’ equity": "18,411.1"
    },
    "Cash Flow Statement": {
      "Net cash provided by (used in) operating activities": "2,207.3",
      "Net cash provided by (used in) investing activities": "-1,375.0",
      "Net cash provided by (used in) financing activities": "-934.1",
      "Effect of changes in exchange rates on cash": "15.5",
      "Net increase (decrease) in cash and cash equivalents": "-86.3",
      "Cash and cash equivalents, end of period": "3,476.4",
      "Short-term investments, end of period": "0.0",
      "Cash and cash equivalents and short-term investments": "3,476.4",
      "Purchases of property, plant and equipment and intangible assets": "-645.5",
      "Free cash flow": "1,561.8",
      "Net income": "2,003.0",
      "Depreciation and amortization": "497.2",
      "Impairment and loss on disposal": "1.2",
      "Share-based compensation expense": "37.3",
      "Inventory reserves": "N/A",
      "Deferred tax expense (benefit)": "-65.8",
      "Equity method investments": "6.1",
      "Accounts receivable, net": "-154.5",
      "Finance receivables, net": "-31.7",
      "Inventories": "-436.1",
      "Other assets": "-74.5",
      "Accrued and other liabilities": "205.2",
      "Accounts payable": "199.6",
      "Current tax assets and liabilities": "196.5",
      "Contract assets and liabilities": "N/A",
      "Purchase of property, plant and equipment": "-612.4",
      "Purchase of intangible assets": "-33.1",
      "Purchase of short-term investments": "0.0",
      "Maturity of short-term investments": "0.0",
      "Loans issued and other investments": "-706.5",
      "Net cash used in investing activities": "-1,375.0"
    }
  },
  "tokens_used": 178934
}